Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Intercure Ltd. (INCR)

$0.97 +1.36% NASDAQ: INCR · 15-min delayed
  • Public · NASDAQ: INCR
  • 285 employees
$55.8MMarket cap
285Employees
INCRNASDAQ
2019IPO

About Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$55.8M
Gross margin
53.9%
Operating margin
-1.1%
Net margin
-5.2%
Multi-year

Revenue & profit trend

Revenue Net income
FY 2017

Financial statements

Income statement

Revenue
$2.7B
Cost of revenue
$1.2B
Gross profit
$1.4B
Operating expenses
$1.5B
Operating income
-$28.9M
Income tax
$26.6M
Net income
-$138.5M
EPS (basic)
$-1.85
EPS (diluted)
$-1.85

Balance sheet

Total assets
$7.3B
Current assets
$1.4B
Total liabilities
$4.3B
Current liabilities
$1.2B
Shareholders’ equity
$3.0B

Cash flow

Operating cash flow
$198.3M
Investing cash flow
-$1.7B
Financing cash flow
$1.7B
Net cash flow
$218.8M

Statements via Polygon.io (SEC filings)

NASDAQ: INCR
$0.97 +1.36%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.73 $1.73

52-week range

Market cap
$55.8M
EPS (diluted)
$-1.85
Shares outstanding
57.5M
Open
Day range
Prev close
Volume
IPO date
Jan 1, 2019

Intercure Ltd. (INCR) Stock Price

  • Revenue grew 127% from FY2014 to FY2017.
  • Gross margin of 53.9%, net margin -5.2%.
  • Trading 44% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Intercure Ltd..

Write a review
Newsroom

News about Intercure Ltd.

News & sentiment via Polygon.io

FAQ

Intercure Ltd.: frequently asked questions

Is Intercure Ltd. an American company?

Intercure Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Intercure Ltd. publicly traded?

Yes — Intercure Ltd. is a publicly traded company. Its stock trades under the ticker symbol INCR on the NASDAQ.

What does Intercure Ltd. do?

Intercure Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →